CARDERO RESOURCE

Research CARDERO RESOURCE (CR5) on Bullrun: market cap EUR 664.27M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCR5
• ExchangeF
• CountrySwitzerland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 664.27M
• Financial periodQ4 2025
• Net income-EUR 23.51M
• Free cash flow-EUR 16.72M

Valuation Snapshot

latest market cap is EUR 664.27M.

About CARDERO RESOURCE

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease;

Frequently asked questions

What is CARDERO RESOURCE's market cap?

CARDERO RESOURCE's market capitalization is EUR 664.27M.

What does CARDERO RESOURCE do?

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.